XT
CRBP icon

XTX Topco’s Corbus Pharmaceuticals CRBP Stock Holding History

XTX Topco’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$357K Buy
+38,023
New +$320K 0.01% 2333
2024
Q2 		– Sell
-10,290
Closed -$404K – 1964
2024
Q1 		$404K Buy
+10,290
New +$254K 0.05% 617
2022
Q1 		– Sell
-1,149
Closed -$21K – 713
2021
Q4 		$21K Sell
1,149
-238
-17% -$6.45K 0.01% 625
2021
Q3 		$42K Buy
+1,387
New +$54.7K 0.01% 612

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Topco's CRBP Position: Q1 2026 in Review

XTX Topco opened a new position in Corbus Pharmaceuticals (CRBP) in Q1 2026: 38,023 shares worth $357K. The stake represents 0.01% of the portfolio and ranks #2333 among its holdings. This is a return to the name: XTX Topco previously reported a position in CRBP as recently as Q1 2024.

XTX Topco first reported a position in CRBP in Q3 2021 and has held it in 4 quarters since. The position peaked at $404K in Q1 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2026.

  • XTX Topco held 38,023 shares of Corbus Pharmaceuticals worth $357K as of Q1 2026.
  • Corbus Pharmaceuticals was a new XTX Topco position in Q1 2026.
  • Corbus Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2333 holding.
  • XTX Topco first reported a position in Corbus Pharmaceuticals in Q3 2021 and has held it in 4 quarters since.
  • XTX Topco's Corbus Pharmaceuticals position peaked at $404K in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.